Assignee
VAXIMM AG
CH·10 granted patents·7 pending applications·49 citations·filing 2012–2022
Top patents by PatentIndex Score
17 records- 0196US11590215B2Process for the production of a DNA vaccine for cancer immunotherapyVAXIMM AG·Filed 2020·Granted Feb 28, 2023·6 cites·7 claims
- 0295US10293037B2DNA vaccine for use in pancreatic cancer patientsVAXIMM AG·Filed 2018·Granted May 21, 2019·10 cites·18 claims
- 0394US9415098B2DNA vaccine for use in pancreatic cancer patientsVAXIMM AG·Filed 2013·Granted Aug 16, 2016·17 cites·14 claims
- 0492US10821163B2Process for the production of a DNA vaccine for cancer immunotherapyVAXIMM AG·Filed 2017·Granted Nov 3, 2020·7 cites·13 claims
- 0584US10980868B2VEGFR-2 targeting immunotherapy approachVAXIMM AG·Filed 2018·Granted Apr 20, 2021·2 cites·21 claims
- 0683US10815455B2Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1VAXIMM AG·Filed 2018·Granted Oct 27, 2020·3 cites·14 claims
- 0777US10905752B2VEGFR-2 targeting DNA vaccine for combination therapyVAXIMM AG·Filed 2016·Granted Feb 2, 2021·1 cites·8 claims
- 0875US9920297B2Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene WT1VAXIMM AG·Filed 2014·Granted Mar 20, 2018·3 cites·15 claims
- 0967US2022273782A1Novel PD-L1 Targeting DNA Vaccine for Cancer ImmunotherapyVAXIMM AG·Filed 2022·Application pending·0 cites
- 1064US11357842B2PD-L1 targeting DNA vaccine for cancer immunotherapyVAXIMM AG·Filed 2018·Granted Jun 14, 2022·0 cites·14 claims
- 1161US2021077605A1Vegfr-2 targeting dna vaccine for combination therapyVAXIMM AG·Filed 2020·Application pending·0 cites
- 1258US2016250311A1Dna vaccine for use in pancreatic cancer patientsVAXIMM AG·Filed 2016·Application pending·0 cites
- 1353US2023121528A1Salmonella-based dna vaccines in combination with an antibioticVAXIMM AG·Filed 2021·Application pending·0 cites
- 1446US2021213121A1Neoantigen targeting dna vaccine for combination therapyVAXIMM AG·Filed 2019·Application pending·0 cites
- 1539US2023158133A1Wt1 targeting dna vaccine for combination therapyVAXIMM AG·Filed 2017·Application pending·0 cites
- 1637US9493738B2Method for producing high yield attenuated Salmonella strainsVAXIMM AG·Filed 2012·Granted Nov 15, 2016·0 cites·15 claims
- 1737US2018153976A1Novel cmv pp65 targeting dna vaccine for cancer immunotherapyVAXIMM AG·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VAXIMM AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →